Patent Power In Congress Will Shift Some In House, Less In Senate After Election
Executive Summary
House Judiciary Committee is losing six of its 39 members, four of whom serve on the intellectual property subcommittee, and the chair is stepping down due to term limits. Two members of the Senate Judiciary Committee are retiring; members seeking re-election retain their seats.
You may also be interested in...
Biologics Data Protection In Trade Agreements Becoming Key Focus For PhRMA
At a House hearing PhRMA representative cites the need for 12 years test data exclusivity for biologics in the Trans-Pacific Partnership Agreement. Separately, USTR issues its 2012 Special 301 Report.
White House Credits Eli Lilly With Help In Final Deal On Patent Reform Bill
At President Obama's urging the CEOs of Lilly and Cisco met with Commerce Department officials to hammer out their differences to get the legislation through Congress.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.